Core Viewpoint - RBC Capital has raised the price target for FTAI Aviation (FTAI) to $350 from $270 while maintaining an Outperform rating on the shares, indicating strong confidence in the company's future performance [1]. Group 1: Price Target and Rating - The price target for FTAI has been increased to $350 from $270 [1]. - RBC Capital continues to hold an Outperform rating on FTAI shares, suggesting a positive outlook for the stock [1]. Group 2: Strategic Developments - The recent partnership with CFM International is highlighted as the most strategically significant announcement from FTAI [1]. - FTAI is now positioned to exceed previous expectations for CFM56 in terms of both revenues and margins, indicating a strong competitive position [1]. - The company is viewed as the leading non-OEM player in the CFM56 aftermarket, which could enhance its market share and profitability [1].

Company Overview - Inspire Medical Systems, Inc. specializes in innovative medical solutions for sleep apnea treatment, particularly known for its Inspire therapy, which serves as an alternative to traditional CPAP machines [1] Stock Performance - The current stock price of INSP is $81.33, reflecting a 2.43% increase or $1.93, with fluctuations between $78.17 and $81.76 throughout the day [4] - Over the past year, INSP has experienced significant volatility, with a high of $203.12 and a low of $70.77 [4] - The company's market capitalization is approximately $2.41 billion, with a trading volume of 1,084,065 shares on the NYSE [4] Analyst Insights - RBC Capital has set a price target of $90 for INSP, indicating a potential upside of approximately 10.66% from the current trading price [2][5] - Baillie Gifford & Co. has reduced its stake in INSP by 2.7%, selling 29,538 shares, leaving them with 1,084,350 shares valued at $80.5 million, which represents about 3.67% of the company [2][5] Institutional Investor Activity - The Texas Permanent School Fund Corp has increased its holdings in INSP by 42.2%, acquiring an additional 11,892 shares, bringing their total to 40,042 shares valued at $5.2 million [3] - Nordea Investment Management AB has entered a new position in INSP, investing approximately $1.6 million during the second quarter [3]

Core Viewpoint - Wheaton Precious Metals Corp. (NYSE:WPM) is recognized as one of the best-performing silver stocks to buy, with positive outlooks from multiple financial institutions [1]. Group 1: Analyst Upgrades - RBC Capital has raised Wheaton Precious Metals' price target from $115 to $130 and upgraded its rating from Sector Perform to Outperform, citing strong protection against guideline season risks and excellent valuation levels compared to producers [2]. - Jefferies maintained a Buy recommendation and increased its price target for Wheaton Precious Metals from $137 to $145, expressing bullish sentiment on gold companies and anticipating improved margins and free cash flow in 2026 compared to 2025 [3]. Group 2: Company Overview - Wheaton Precious Metals Corp. operates as a precious metals streaming corporation, indicating a focus on the streaming model in the precious metals sector [4].

Core Insights - Northern Trust Corp (NASDAQ:NTRS) is a prominent financial services company specializing in asset management, asset servicing, and wealth management, competing with firms like State Street and BNY Mellon [1] Financial Performance - In Q4 2025, Northern Trust reported a 9% increase in overall revenue, with trust fees rising by 7% and net interest income increasing by 14% to $654 million [2] - The company's earnings per share (EPS) experienced a significant 19% increase, and the pretax margin expanded to 33% [2][5] Shareholder Returns - Northern Trust returned $1.9 billion to shareholders in 2025, which included a record $1.3 billion in share repurchases, resulting in a 5% reduction in share count [3][5] Asset Management Performance - The asset management division achieved 12 consecutive quarters of positive flows, with liquidity assets under management (AUM) reaching nearly $340 billion [3] Stock Performance - The current stock price of NTRS is approximately $148.84, reflecting a decrease of about 2.80% or $4.28, with a market capitalization of approximately $28.15 billion [4] - Over the past year, the stock has fluctuated between a high of $157.60 and a low of $81.62 [4] Price Target - RBC Capital has set a new price target of $159 for NTRS, indicating a potential 6.79% increase from its current trading price [1][5]

Silicon Laboratories Inc. (NASDAQ:SLAB) is one of the best mid-cap growth stocks to buy right now. On January 15, RBC Capital initiated coverage of Silicon Labs with a Sector Perform rating and $160 price target. The company is starting to see the benefits of a healthier market as old stock finally clears out of the supply chain. Despite this positive trend, the firm isn’t ready to recommend buying the stock yet and wants to wait and see if the company’s new Wi-Fi tech actually takes off first. Earlier o ...

We recently published 15 Stocks on Jim Cramer’s Radar.  Alphabet Inc. (NASDAQ:GOOGL) is one of the stocks on Jim Cramer's radar. Over the past couple of months, Jim Cramer has turned increasingly optimistic on Alphabet Inc. (NASDAQ:GOOGL). Several factors have driven his optimism. Early on, these included enthusiasm for YouTube and the firm’s dominance in the search engine market. More recently, Alphabet Inc. (NASDAQ:GOOGL)’s Gemini AI platform has landed on the CNBC TV host’s radar. He correctly predicte ...

Core Insights - Huntington Bancshares Incorporated (NASDAQ:HBAN) is identified as one of the best undervalued wide moat stocks [1] - RBC Capital has raised its price target for HBAN from $20.00 to $21.00, maintaining an 'Outperform' rating due to stable regional bank fundamentals and a positive outlook for Q4 earnings [2] - The merger between Huntington Bancshares and Cadence Bank is set to close on February 1, 2026, which is expected to enhance capabilities and shareholder value [2] Company Developments - The merger approval by shareholders of both Huntington Bancshares and Cadence Bank is a significant milestone, with expectations of synergies and expanded reach [2] - Cadence CEO James D. Rollins III emphasized the relationship-focused philosophies of both banks and the opportunities the merger presents for customers [2] - Huntington Bancshares provides a range of services including consumer and commercial banking, deposits, lending, payments, and wealth management [2] Market Outlook - The investment firm RBC Capital believes that strengthening loan and revenue growth will be key drivers for HBAN, contributing to a stable outlook for the banking sector compared to the previous quarter [2] - Despite the potential of HBAN as an investment, there is a suggestion that certain AI stocks may offer greater upside potential with less downside risk [2]

Masco Corporation (NYSE:MAS) is included on our list of the best undervalued wide moat stocks. Wells Fargo Bullish on Masco (MAS) Ahead of Q4 2025 Results Announcement On January 14, 2026, Masco Corporation (NYSE:MAS) saw Wells Fargo analyst Sam Reid raise the firm’s price target from $75.00 to $78.00 and reiterate an ‘Overweight’ rating. With 2026 off to a volatile start ahead of quarterly results, the investment firm says homebuilders’ stocks look risky after the rally, and the outlook on building prod ...

Core Viewpoint - The Law Offices of Howard G. Smith is investigating potential claims against the board of directors of Cogent Communications Holdings, Inc. regarding possible breaches of fiduciary duties to shareholders [1][3]. Group 1: Investigation Details - The investigation focuses on whether the board of directors of Cogent mismanaged the company and breached its fiduciary duties in connection with the seizure of $82 million in shares pledged by CEO Dave Schaeffer as collateral for loans [3]. Group 2: Shareholder Participation - Shareholders of Cogent Communications Holdings, Inc. who purchased shares before August 2025 are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights and potential participation in the investigation [2][4].

Core Viewpoint - The article discusses the potential of undervalued wide moat stocks as U.S. markets transition into 2026, highlighting a shift in macroeconomic conditions that may favor small-cap stocks due to expected earnings growth and easing interest rates [1][2]. Market Outlook - Analysts predict two 25-basis-point rate cuts by the Federal Reserve in 2026, which could benefit small-cap companies with high debt levels [3]. - The Russell 2000 index is expected to rise to 2,825 by the end of 2026, indicating a projected gain of approximately 14% from 2025 levels [3]. Sector Analysis - Healthcare and financial sectors are identified as key beneficiaries of favorable policies, M&A activity, and AI-related efficiency improvements [5]. - The banking segment is projected to outperform in 2026, prompting investors to seek stocks with strong fundamentals and competitive positioning [5]. Investment Methodology - The analysis utilizes the VanEck Morningstar Wide Moat ETF to identify undervalued stocks, filtering for those trading at least 25% below the S&P 500's forward P/E of 22.34 as of January 16, 2026 [7]. - Hedge fund sentiment is considered, with a focus on stocks held by a significant number of hedge funds, as this strategy has historically outperformed the market [8]. Company Highlights - **Zimmer Biomet Holdings, Inc. (NYSE:ZBH)**: - Forward P/E of 10.27x with 35 hedge fund holders; cautious expectations for 2026 were communicated at the J.P. Morgan Healthcare Conference [10][11]. - Management revised 2025 organic revenue growth forecast down to 4.00% from 4.50% due to weaker demand in certain regions, but overall revenue growth estimates remained stable [12]. - **Huntington Bancshares Incorporated (NASDAQ:HBAN)**: - Forward P/E of 10.60x with 42 hedge fund holders; RBC Capital raised its price target from $20.00 to $21.00, citing stable fundamentals and a positive outlook [15][16]. - The company is set to merge with Cadence Bank, expected to enhance capabilities and shareholder value [17]. - **Masco Corporation (NYSE:MAS)**: - Forward P/E of 16.67x with 44 hedge fund holders; Wells Fargo raised its price target from $75.00 to $78.00, while RBC Capital lowered its target from $69.00 to $67.00, reflecting mixed outlooks in the building products sector [19][20][21].